(Q42487474)

1 November 2017

title

Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women (English)

1 reference

1 November 2017

4

Moyses Szklo

1 reference

1 November 2017

1

Aaron R Folsom

1 reference

1 November 2017

Sherita Hill Golden

2

1 reference

1 November 2017

Lori L Boland

series ordinal

3

1 reference

1 November 2017

language of work or name

1 reference

1 January 2005

1 reference

European Journal of Epidemiology

1 November 2017

published in

1 reference

1 November 2017

volume

20

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

1015-1022

1 reference

https://scigraph.springernature.com/pub.10.1007/s10654-005-3657-0

1 November 2017

exact match

0 references

cites work

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-005-3657-0

The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

12 December 2020

Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management

1 reference

12 December 2020

The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial

1 reference

12 December 2020

Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women

1 reference

12 December 2020

Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort

1 reference

12 December 2020

Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women

1 reference

12 December 2020

Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women

1 reference

12 December 2020

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

1 reference

12 December 2020

Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women

1 reference

12 December 2020

Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis

1 reference

12 December 2020

Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women

1 reference

12 December 2020

[Plasma concentration of C-reactive protein in patients with high estrogen levels]

1 reference

12 December 2020

Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults

1 reference

12 December 2020

Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment

1 reference

12 December 2020

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

1 reference

12 December 2020

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

12 December 2020

Sex hormones and systemic lupus erythematosus

1 reference

12 December 2020

Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women

1 reference

12 December 2020

Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen

1 reference

12 December 2020

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

1 reference

12 December 2020

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein.

1 reference

12 December 2020

Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women

1 reference

12 December 2020

Hormonal abnormalities in obesity.

1 reference

12 December 2020

Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings

1 reference

12 December 2020

Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial.

1 reference

12 December 2020

High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. The ARIC Study Group

1 reference

12 December 2020

Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women

1 reference

12 December 2020

Reliability and interrelations among serum sex hormones in postmenopausal women

1 reference

12 December 2020

Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

1 reference

12 December 2020

C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study

1 reference

12 December 2020

Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation

1 reference

12 December 2020

Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein.

1 reference

12 December 2020

Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience

1 reference

12 December 2020

Effects of hormone replacement therapy on hemostatic cardiovascular risk factors

1 reference

12 December 2020

10.1007/S10654-005-3657-0

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1045379953

0 references

Fatcat ID

release_67yhblhbe5cfdni5tttisrd5ci

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/67yhblhbe5cfdni5tttisrd5ci

24 November 2022

mapped directly with Wikidata item

1 reference